Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F65Y5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,313
Award facts
- Contract value 100% obligated
- $12,312.91 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded January 16, 2026, provides for the supply of Repatha 140 mg/ml SureClick medication to the Defense Logistics Agency (DLA) through a competitively awarded, firm fixed-price contract with a ceiling value of $12,312.91. The award was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, with an ultimate completion date of January 20, 2026. No set-aside designation was applied to this procurement, indicating full and open competition. The contract represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026, which serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp operates as a subsidiary of parent company Cencora, Inc. (formerly doing business as AmerisourceBergen), which holds the overarching IDC with DLA. The company's federal procurement portfolio demonstrates extensive capability in delivering specialized pharmaceutical products across multiple therapeutic domains to military treatment facilities, veterans' healthcare programs, and other federal medical institutions. DLA Troop Support Medical utilizes this contract structure to efficiently procure critical medications and medical supplies needed to support defense and military healthcare operations worldwide.
Quick answers
Who was awarded contract SPE2DR26F65Y5?
SPE2DR26F65Y5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26F65Y5 worth?
The government has obligated $12,313 on SPE2DR26F65Y5.
Is contract SPE2DR26F65Y5 an order under another contract?
Yes. SPE2DR26F65Y5 is a delivery order under SPE2DR25D3303, an indefinite delivery contract.
Was contract SPE2DR26F65Y5 competed?
The extent of competition for SPE2DR26F65Y5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award